CJC-1295 w/o DAC 10mg Peptides

Engineered for controlled studies, this lyophilized peptide is prepared to meet rigorous laboratory expectations from the first inspection to final documentation.

Primavora CJC-1295 without DAC is supplied as a lyophilized research peptide vial, prepared in a clean, unflavored format to support precise laboratory work. This single-vial presentation contains a total of 10mg of the active peptide, enabling consistent preparation and straightforward batch traceability in controlled research settings.

CJC-1295 without Drug Affinity Complex (DAC) is frequently selected for studies where investigators seek a shorter observational window and a profile consistent with pulsatile dynamics. This format supports protocols that prioritize timing control and flexible sampling across defined intervals, without the prolonged residence associated with DAC-bound variants.

  • Each vial contains 10mg of CJC-1295 without DAC, a research peptide investigated for its kinetics aligned to pulsatile signaling models and for applications where a shorter study horizon is desired.

The lyophilized powder is designed for laboratory reconstitution according to qualified protocols. Researchers often value the clear handling characteristics of a properly lyophilized cake, which supports accurate volumetric preparation and visual assessment during setup. The vial format is intended for benchtop consistency, enabling standardized aliquoting, repeatable mixing, and defined storage parameters as dictated by the study design.

Every Primavora lot is produced and handled in the USA under stringent quality systems. Batches undergo third-party analytical testing for identity and purity (including methods such as HPLC/LC-MS), with results documented in batch-specific Certificates of Analysis. Materials are managed in controlled environments with meticulous chain-of-custody records, tamper-evident packaging, and clear lot labeling to support audit-readiness and reproducible work across replicates.

Research-use positioning: This product is intended strictly for laboratory research applications by qualified professionals. It is not a drug, food, or cosmetic; not for human consumption, medical, or veterinary use. Preparation, storage, and disposal should follow institutional guidelines and applicable regulations.

Trust in disciplined quality: Primavora emphasizes purity, consistency, and documentation at every step—careful sourcing, cGMP-aligned handling, and independent verification—so investigators can focus on protocol design and data integrity with confidence in the material they’re working with.

Total Strength
10mg
Strength Per vial
10mg/vial
Total Units
1 vial
Weight
0.70oz
Total CJC-1295 w/o DAC Compounds
10mg
CJC-1295 w/o DAC Compounds Per vial
10mg/vial

  • Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
  • Shipping is free on orders of $99+ (except Hawaii and Alaska).
  • All orders ship in discreet packaging via USPS Ground Advantage mail.

Delivery restrictions vary by state.

Also Available In Research Kits

Customer Reviews

There are no reviews yet. Be the first to write a review!

Frequently Asked Questions

What are GH peptides?

GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).

Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.

How do GH peptides differ from recombinant growth hormone?

Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.

This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.

What is the difference between GHRH analogs and GH secretagogues?

GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.

GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.

Recently Viewed